Payment overview · 2025
General Payments
$103.62
5 reported records · 3 companies
Healthcare provider profile · identity verified
Daniel R Berg, MD
Allopathic & Osteopathic Physicians|Family Medicine · NEW PRAGUE, MN · NPI 1659362069
Verified facts
What the public records show
CMS Open Payments records show Daniel R Berg, MD received $103.62 in general payments during 2025 across 5 reported records.
Esperion Therapeutics, Inc. accounted for 48.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $50.43 | 48.7% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $38.90 | 37.5% | 2 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$14.29 | 13.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $103.62 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $50.43 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $38.90 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $38.90 | 2 | 2025 |
Source payment records
|
|||||
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $14.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 520 | 146 |
| Atorvastatin Calcium | Atorvastatin Calcium | 423 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 391 | 120 |
| Levothyroxine Sodium | Levothyroxine Sodium | 228 | 62 |
| Simvastatin | Simvastatin | 220 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 195 | 67 |
| Azithromycin | Azithromycin | 194 | 112 |
| Lisinopril | Lisinopril | 179 | 53 |
| Omeprazole | Omeprazole | 174 | 45 |
| Atenolol | Atenolol | 171 | 49 |
| Valsartan | Valsartan | 171 | 56 |
| Furosemide | Furosemide | 163 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 42 |
| Losartan Potassium | Losartan Potassium | 151 | 42 |
| Spironolactone | Spironolactone | 150 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 145 | 42 |
| Famotidine | Famotidine | 135 | 49 |
| Eliquis | Apixaban | 134 | 33 |
| Prednisone | Prednisone | 129 | 54 |
| Metformin Hcl | Metformin Hcl | 119 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 112 | 28 |
| Warfarin Sodium | Warfarin Sodium | 108 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 32 |
| Gabapentin | Gabapentin | 104 | 29 |
| Allopurinol | Allopurinol | 92 | 29 |
| Pioglitazone Hcl | Pioglitazone Hcl | 92 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 78 | 22 |
| Potassium Chloride | Potassium Chloride | 77 | 28 |
| Trazodone Hcl | Trazodone Hcl | 73 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 72 | 24 |
| Cephalexin | Cephalexin | 68 | 51 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 61 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 60 | 18 |
| Ramipril | Ramipril | 56 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 55 | 15 |
| Carvedilol | Carvedilol | 52 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 51 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 51 | 20 |
| Ezetimibe | Ezetimibe | 51 | 19 |
| Celecoxib | Celecoxib | 50 | 21 |
| Jardiance | Empagliflozin | 49 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 32 |
| Sertraline Hcl | Sertraline Hcl | 47 | 13 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 47 | 38 |
| Metformin Hcl Er | Metformin Hcl | 46 | 18 |
| Ozempic | Semaglutide | 46 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 45 | 25 |
| Finasteride | Finasteride | 43 | 15 |
| Amoxicillin | Amoxicillin | 42 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 42 | 21 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 42 | 21 |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 29 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 30 |
| Pregabalin | Pregabalin | 39 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 38 | 12 |
| Ketoconazole | Ketoconazole | 37 | 23 |
| Mupirocin | Mupirocin | 37 | 20 |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 35 | 35 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 34 | 11 |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | 11 |
| Jantoven | Warfarin Sodium | 31 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Gemfibrozil | Gemfibrozil | 29 | suppressed |
| Levetiracetam | Levetiracetam | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 27 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | 11 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 25 | suppressed |
| Carbamazepine Er | Carbamazepine | 25 | suppressed |
| Eplerenone | Eplerenone | 25 | suppressed |
| Estradiol | Estradiol | 25 | 12 |
| Repatha Sureclick | Evolocumab | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 24 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 24 | 15 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 19 |
| Lorazepam | Lorazepam | 23 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 22 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Alprazolam | Alprazolam | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 11 |
| Torsemide | Torsemide | 20 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 18 |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Latanoprost | Latanoprost | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Cefdinir | Cefdinir | 17 | 12 |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | 11 |
| Prazosin Hcl | Prazosin Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | suppressed |
| Zemaira | Alpha-1-Proteinase Inhibitor | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Ofloxacin | Ofloxacin | 12 | 12 |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Glyburide | Glyburide | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $103.62 · 5 records | Esperion Therapeutics, Inc. | MINIMED 780G, NEXLETOL, OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error